Femasys (FEMY) Receivables (2020 - 2026)
Femasys (FEMY) reported Receivables of $172264.0 for Q1 2026, down 26.26% on a YoY basis from $233598.0 in Q1 2025, and down 72.06% quarter-over-quarter from $616600.0 in Q4 2025.
Femasys (FEMY) Receivables (2020 - 2026) Analysis & Trends
Femasys has reported Receivables for 7 years, with the latest figure at $172264.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables fell 26.26% year-over-year to $172264.0; the trailing twelve-month figure through Mar 2026 stood at $172264.0 (down 26.26% YoY), and the FY2025 full-year result was $616600.0, up 26.26% from the prior year.
- Receivables for Q1 2026 stood at $172264.0, down from $616600.0 in the prior quarter.
- The five-year high for Receivables was $616600.0 in Q4 2025, with the low at $77470.0 in Q4 2022.
- Historically, Receivables has averaged $232705.7 across 5 years, with a median of $170302.0 in 2022.
- Annual changes were most pronounced in 2023 — Receivables plunged 43.45% — and 2024, when it surged 393.77%.
- Femasys' Receivables stood at $77470.0 in 2022, then gained by 27.67% to $98906.0 in 2023, then surged by 393.77% to $488373.0 in 2024, then advanced by 26.26% to $616600.0 in 2025, then sank by 72.06% to $172264.0 in 2026.
- The last three Receivables figures came in at $172264.0 (Q1 2026), $616600.0 (Q4 2025), and $572199.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.62 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.21 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 3.67 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.05 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 701.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 1.18 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 809.20 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.13 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 1.68 Bn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | 172,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172,264.00 |
| Dec 31, 2025 | 616,600.00 |
| Sep 30, 2025 | 572,199.00 |
| Jun 30, 2025 | 254,584.00 |
| Mar 31, 2025 | 233,598.00 |
| Dec 31, 2024 | 488,373.00 |
| Sep 30, 2024 | 378,290.00 |
| Jun 30, 2024 | 92,535.00 |
| Mar 31, 2024 | 120,529.00 |
| Dec 31, 2023 | 98,906.00 |
| Sep 30, 2023 | 103,556.00 |
| Jun 30, 2023 | 155,746.00 |
| Mar 31, 2023 | 123,955.00 |
| Dec 31, 2022 | 77,470.00 |
| Sep 30, 2022 | 183,130.00 |
| Jun 30, 2022 | 113,960.00 |
| Mar 31, 2022 | 170,302.00 |
| Dec 31, 2021 | 84,258.00 |
| Sep 30, 2021 | 143,459.00 |
| Jun 30, 2021 | 158,837.00 |